Clinical Trial Update: Observational Registry of the Treatment of Glanzmann's Thrombasthenia

View source ↗

Summary

This entry reports completion of an observational registry studying treatments for Glanzmann thrombasthenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glanzmann Thrombasthenia

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Glanzmann's Disease | Status: COMPLETED